Get the Stockscreener App
16.50
8.59%
-1.55
Pre-market:
16.56
0.06
+0.36%
Scilex Holding Company stock is traded at $16.50, with a volume of 219.10K.
It is down -8.59% in the last 24 hours and down -16.16% over the past month.
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
See More
Previous Close:
$18.05
Open:
$18.05
24h Volume:
219.10K
Relative Volume:
0.90
Market Cap:
$114.77M
Revenue:
$46.74M
Net Income/Loss:
$-114.33M
P/E Ratio:
-12.79
EPS:
-1.29
Net Cash Flow:
$-21.04M
1W Performance:
+1.16%
1M Performance:
-16.16%
6M Performance:
+248.10%
1Y Performance:
-50.91%
1-Day Range:
$16.05
$18.50
1-Week Range:
$16.05
$20.02
52-Week Range:
$3.60
$39.90
Scilex Holding Company Stock (SCLX) Company Profile
Name
Scilex Holding Company
Sector
Industry
Phone
(650) 516-4310
Address
960 SAN ANTONIO ROAD, PALO ALTO
Compare SCLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SCLX
Scilex Holding Company
|
16.50 | 133.68M | 46.74M | -114.33M | -21.04M | -1.29 |
|
LLY
Lilly Eli Co
|
862.86 | 757.06B | 59.42B | 18.41B | -50.20M | 20.22 |
|
JNJ
Johnson Johnson
|
188.87 | 455.48B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
218.04 | 403.13B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
123.79 | 235.26B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
85.98 | 215.51B | 63.99B | 19.05B | 14.72B | 7.5596 |
Scilex Holding Company Stock (SCLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-25 | Initiated | D. Boral Capital | Buy |
| Oct-16-24 | Initiated | Alliance Global Partners | Buy |
| Jun-13-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-16-23 | Initiated | B. Riley Securities | Buy |
| Oct-13-23 | Initiated | B. Riley Securities | Buy |
| Oct-09-23 | Initiated | H.C. Wainwright | Buy |
View All
Scilex Holding Company Stock (SCLX) Latest News
Applying chart zones and confluence areas to Scilex Holding Company Equity WarrantQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Will Scilex Holding Company Equity Warrant stock outperform tech sector in 20252025 Retail Activity & Real-Time Volume Analysis - newser.com
Comparing Scilex Holding Company in custom built stock radarsJuly 2025 WrapUp & Precise Entry and Exit Recommendations - newser.com
How Scilex Holding Company Equity Warrant stock benefits from global expansionJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Market reaction to Scilex Holding Company’s recent newsEarnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
Can Scilex Holding Company Equity Warrant stock resist sector downturnsMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
Scilex Holding Company (NASDAQ:SCLX) Sees Significant Decrease in Short Interest - MarketBeat
Real time alert setup for Scilex Holding Company performanceJuly 2025 Movers & Low Drawdown Momentum Ideas - newser.com
Scilex Holding ends equity line agreement with Tumim Stone Capital By Investing.com - Investing.com Canada
Scilex Ends Stock Purchase Agreement with Tumim - TipRanks
Scilex Holding ends equity line agreement with Tumim Stone Capital - Investing.com
Using data models to predict Scilex Holding Company stock movementWeekly Trading Summary & AI Forecast Swing Trade Picks - newser.com
Is Scilex Holding Company trending in predictive chart modelsJuly 2025 Movers & Smart Allocation Stock Reports - newser.com
Momentum divergence signals in Scilex Holding Company chartChart Signals & AI Enhanced Market Trend Forecasts - newser.com
How to integrate Scilex Holding Company Equity Warrant into portfolio analysis toolsJuly 2025 Review & Target Return Focused Picks - newser.com
What technical models suggest about Scilex Holding Company Equity Warrant’s comebackJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - newser.com
Order flow analysis tools used on Scilex Holding CompanyEarnings Recap Report & Weekly Top Gainers Alerts - newser.com
Technical signs of recovery in Scilex Holding CompanyJuly 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
Using portfolio simulators with Scilex Holding Company Equity Warrant includedOptions Play & Weekly Return Optimization Plans - newser.com
What drives Scilex Holding Company stock priceContrarian Investment Ideas & Predict Volatility With Our Neural Network - earlytimes.in
Is Scilex Holding Company stock in correction or buying zoneWeekly Investment Report & AI Optimized Trade Strategies - newser.com
Will Scilex Holding Company stock remain a Wall Street favoriteMarket Sentiment Summary & Technical Entry and Exit Tips - newser.com
Scilex Holding Company (NASDAQ:SCLX) Is Expected To Breakeven In The Near Future - Yahoo Finance
Scilex Holding Company Stock (SCLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.71%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):